R&D Tax Credit for Biotech and Life Sciences

Biotech and life sciences companies are natural candidates for the R&D tax credit. Drug development, diagnostic testing, laboratory process optimization, and biological research frequently involve the kind of technological uncertainty and systematic experimentation that the credit rewards.

What qualifies

Biotech and life sciences R&D qualifies when it meets the four-part test. Most research conducted in this industry inherently involves biological or physical science and systematic experimentation — the two criteria that other industries sometimes struggle to demonstrate.

Common qualifying activities

Drug and therapeutic development

Designing and synthesizing new compounds where biological activity is uncertain
Developing drug delivery mechanisms (formulation, encapsulation, targeted delivery)
Conducting preclinical studies to evaluate safety, efficacy, or pharmacokinetics
Developing manufacturing processes for biological products where yield, purity, or stability outcomes are uncertain
Scaling up from laboratory to pilot to commercial production where process parameters must be re-established

Diagnostics and medical devices

Developing new assays or diagnostic tests where sensitivity, specificity, or reproducibility is uncertain
Designing medical devices where performance, biocompatibility, or manufacturing feasibility requires experimentation
Engineering point-of-care testing platforms where miniaturization or integration creates technical challenges
Developing software for medical image analysis or diagnostic interpretation

Laboratory process development

Optimizing extraction, purification, or separation processes where efficiency or yield is uncertain
Developing cell culture methods, fermentation processes, or bioreactor conditions for new organisms or cell lines
Creating new analytical methods where detection limits or accuracy must be established
Automating laboratory workflows where integration of instruments and data systems presents technical challenges

Agricultural biotechnology

Developing new crop varieties, biological pest controls, or soil amendments where efficacy is uncertain
Engineering fermentation or extraction processes for agricultural biologicals
Developing testing methods for agricultural product quality or safety

Bioinformatics and computational biology

Developing algorithms for genomic analysis, protein structure prediction, or molecular modeling
Building data pipelines for processing biological data at scale where performance is uncertain
Creating computational tools for experiment design or result interpretation

What does not qualify

Routine quality control testing using established protocols
Clinical trials conducted purely for regulatory compliance with no technical uncertainty about method
Manufacturing existing products using established processes
Literature reviews and data compilation without experimentation
Market research or business planning for new products

Qualifying expenses

Biotech companies typically generate significant QREs across all categories:

Wages — scientists, engineers, lab technicians, and bioinformaticians performing or supporting qualifying research
Supplies — reagents, chemicals, biological materials, lab consumables, and prototype components consumed in R&D
Contract research — CRO services, outside laboratory testing, and contract manufacturing development performed on your behalf

Supply costs can be substantial in this industry, making thorough tracking particularly valuable.

What Qualifies — the four-part test in detail
Qualified Research Expenses — what expenses count
Documentation Requirements — what records to keep
Estimate your credit — free calculator